PAMELA MIZE: Open Payments
NPI 1245726512 · BATESVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$132 in 7 payments from 7 companies in 2025. Trend: 2023 $14 · 2024 $212 · 2025 $132
Food & beverage: $132
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $27 |
| PFIZER INC. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: VRAYLAR, PREVNAR 20, LEQVIO, CAPLYTA, GEMTESA, XYOSTED, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
